Neglected Tropical Diseases Diagnosis Market Analysis Report, 2018 to 2025
by Susan Hill Business ConsultantThe global neglected tropical diseases diagnosis market size is
expected to reach USD 7.6 billion by 2025, according to a new report by Grand
View Research, Inc., exhibiting a 4.1% CAGR during the forecast period. The
combined effect of high impact factors such as soaring disease burden, growing
demand for early disease identification, and complementary advancements in
technology is expected to drive growth in demand.
For instance, the Global Network for Neglected Tropical Diseases aims to
raise awareness and funding, both of which are essential to control and
eliminate the most common NTDs. In addition, various companies are undertaking
efforts to develop less complicated and inexpensive diagnostic assays for
tropical diseases. This, in turn, is anticipated to support the growth of this
market throughout the forecast period.
Further key findings from the report suggest:
- By disease type, dengue captured the largest share over other NTDs
in 2016. Growing dengue cases and development of novel products for its
diagnosis is expected to help this segment maintain its dominance in the
coming years
- Conventional diagnostic methods accounted for the majority share
owing to high market penetration of these techniques, including pathogen
culturing, biochemical methods, gram staining, and serology tests
- Molecular/modern diagnostic methods are growing at a lucrative pace
and are expected to supplant conventional techniques in the coming years.
This is majorly due to the advantages of molecular tests with respect to
accuracy, specificity, and timelines
- Centralized services held the largest share in 2016 owing to easy
access to these services; however, point-of-care testing (POCT) services
are anticipated exhibit lucrative growth in the coming years owing to
benefits such as portability and ease of use
- By end use, home
healthcare is expected to be the fastest growing segment as a result
of growing popularity and demand for POCT services
- Asia Pacific is estimated to be the largest regional market and is
expected to maintain its position throughout the forecast period thanks to
constant growth in GDP, presence of a large target population, and high
prevalence of neglected tropical diseases in the region
- Abbott; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific, Inc.;
and Omega Diagnostics Group PLC are some of the key players operating in
this market.
Access full
research report on global neglected tropical diseases diagnosis market:
www.grandviewresearch.com/industry-analysis/neglected-tropical-diseases-diagnosis-market
Sponsor Ads
Created on Apr 14th 2020 16:16. Viewed 310 times.